Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player?

Vascular Pharmacology

Volumn 60, Issue 1, 2014, Pages 32-41

  Martelli, Alma ^a   Testai, Lara ^a   Citi, Valentina ^a   Marino, Alice ^a   Bellagambi, Francesca G ^a   Ghimenti, Silvia ^a   Breschi, Maria C ^a   Calderone, Vincenzo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

H2S releasing drugs; Hydrogen sulfide; Hypertension; Isothiocyanate; Vascular smooth muscle

Indexed keywords

4 CARBOXYPHENYL ISOTHIOCYANATE; ANGIOTENSIN II; ARYL ISOTHIOCYANATE; CYSTEINE; HYDROGEN SULFIDE; ISOTHIOCYANIC ACID DERIVATIVE; PHENYL ISOTHIOCYANATE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV 7; UNCLASSIFIED DRUG; VASODILATOR AGENT;

AMPEROMETRY; ANIMAL EXPERIMENT; ARTICLE; CONDUCTANCE; CORONARY ARTERY; DRUG EFFECT; HYPERPOLARIZATION; MASS FRAGMENTOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; SPECTROPHOTOMETRY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

2-ISOPROPYL PHENYLISOTHIOCYANATE; 2-TRIFLUOROMETYL PHENYLISOTHIOCYANATE; 4-CARBOXYPHENYL ISOTHIOCYANATE (PUBCHEM CID: 242946); 4-CARBOXYPHENYLISOTHIOCYANATE; AB; ACETYLCHOLINE; ACH; ANGII; ANGIOTENSIN II; ASSAY BUFFER; BISOXONOL DYE BIS-(1,3-DIBUTYLBARBITURIC ACID); CF; CORONARY FLOW; CSE; CYSTATHIONINE-GAMMA-LYASE; DADS; DIALLYL DISULFIDE; DIALLYL DISULFIDE (PUBMED CID: 16590); DIBAC4(3); DIMETHYLSULFOXIDE; DMSO; GYY4137; GYY4137 (PUBMED CID: 53393943); H(2)S; H(2)S-RELEASING DRUGS; HASMC; HEART RATE; HR; HUMAN AORTIC SMOOTH MUSCLE CELL; HYDROGEN SULFIDE; HYDROGEN SULFIDE (PUBCHEM CID: 402); HYPERTENSION; ISOTHIOCYANATE; L-NAME; L-NITROARGININE METHYL ESTER; LEFT VENTRICULAR DEVELOPED PRESSURE; LVDP; METYL-PHENYLISOTHIOCYANATE; MORPHOLIN-4-IUM-4-METHOXYPHENYL-MORPHOLINO-PHOSPHINODITHIOATE; NA; NITRIC OXIDE; NO; NORADRENALINE; PHENYL ISOTHIOCYANATE (PUBCHEM CID: 7673); PHENYLISOTHIOCYANATE; PHNCS; PHNCS-CF(3); PHNCS-CH(3); PHNCS-COOH; PHNCS-IPR; SBP; SMGS; SMOOTH MUSCLE GROWTH SUPPLEMENT; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE; VSM;

ANIMALS; AORTA; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN SULFIDE; ISOTHIOCYANATES; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; VASOCONSTRICTION; VASODILATION;

EID: 84892529669     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.11.003     Document Type: Article

References (36)

1. Hosoki R., Matsuki N., Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997, 237:527-531.
2. Cheng Y., Ndisang J.F., Tang G., Cao K., Wang R. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 2004, 287:H2316-H2323.
3. Zhong G., Chen F., Cheng Y., Tang C., Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 2003, 21:1879-1885.
4. ATP channel opener. EMBO J 2001, 20:6008-6016.
5. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionin gamma-lyase. Science 2008, 322:587-590.
6. 2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol 2008, 155:673-680.
7. Pan L., Liu X., Gong Q., Yang H., Zhu Y. Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?. Antioxid Redox Signal 2012, 17:106-118.
8. Martelli A., Testai L., Breschi M.C., Blandizzi C., Virdis A., Taddei S., et al. Hydrogen sulfide: novel opportunity for drug discovery. Med Res Rev 2012, 32:1093-1130.
9. Li Y.F., Xiao C.S., Hui R.T. Calcium sulfide (CaS), a donor of hydrogen sulfide (H(2)S): a new antihypertensive drug?. Med Hypotheses 2009, 73:445-447.
10. 2S-releasing drugs as pharmaceuticals. J Med Chem 2010, 53:6275-6286.
11. Martelli A., Testai L., Marino A., Breschi M.C., Da Settimo F., Calderone V. Hydrogen sulfide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives. Curr Med Chem 2012, 19:3325-3336.
12. Benavides G.A., Squadrito G.L., Mills R.W., Patel H.D., Isbell T.S., Patel R.P., et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A 2007, 104:17977-17982.
13. Li L., Whiteman M., Guan Y.Y., Neo K.L., Cheng Y., Lee S.W., et al. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulphide. Circulation 2008, 117:2351-2360.
14. 2S) donors. J Am Chem Soc 2011, 12:15-17.
15. 2S donors: L-cysteine-activated releasing properties and vascular effects in vitro and in vivo. ACS Med Chem Lett 2013, 4:904-908.
16. Isenberg J.S., Jia Y., Field L., Ridnour L.A., Sparatore A., Del Soldato P., et al. Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. Br J Pharmacol 2007, 151:63-72.
17. 2S-releasing aspirin. Free Radic Biol Med 2009, 46:586-592. (Erratum in: Free Radic Biol Med 2009;47:1781).
18. Shukla N., Rossoni G., Hotston M., Sparatore A., Del Soldato P., Tazzari V., et al. Effect of hydrogen sulfide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int 2009, 103:1522-1529.
19. Wallace JL, Cirino G, Santagada V, Caliendo G. Hydrogen sulfide derivatives of non-steroidal anti-inflammatory, drugs. 2008;WO2008/009127 A1.
20. Breschi M.C., Calderone V., Digiacomo M., Manganaro M., Martelli A., Minutolo F., et al. Spirocyclic benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel. J Med Chem 2008, 51(21):6945-6954.
21. Martelli A., Testai L., Breschi M.C., Lawson K., McKay N.G., Miceli F., et al. Vasorelaxation by hydrogen sulphide involves activation of K(v)7 potassium channels. Pharmacol Res 2013, 70(1):27-34.
22. Martelli A., Manfroni G., Sabbatini P., Barreca M.L., Testai L., Novelli M., et al. 1,4-Benzothiazine ATP-sensitive potassium channel openers: modifications at the C-2 and C-6 positions. J Med Chem 2013, 56(11):4718-4728.
23. Gopalakrishnan M., Buckner S.A., Shieh C.C., Fey T., Fabiyi A., Whiteaker K.L., et al. Br J Pharmacol 2004, 143(1):81-90.
24. Yasui S., Mawatari K., Kawano T., Morizumi R., Hamamoto A., Furukawa H., et al. Insulin activates ATP-sensitive potassium channels via phosphatidylinositol 3-kinase in cultured vascular smooth muscle cells. J Vasc Res 2008, 45(3):233-243.
25. Dorman D.C., Moulin F.J., McManus B.E., Mahle K.C., James R.A., Struve M.F. Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentration in the rat brain, liver, lung, and nasal epithelium. Toxicol Sci 2002, 65:18-25.
26. Dombkowski R.A., Russel M.J., Olson K.R. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol 2004, 286:R678-R685.
27. Baskar R., Li L., Moore P.K. Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. FASEB J 2007, 21:247-255.
28. Yang G., Sun X., Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB J 2004, 18:1782-1784.
29. Edman P. Preparation of phenyl thiohydantoin from some natural amino acids. Acta Chem Scand 1950, 4:277-282.
30. Li L., Rose P., Moore P.K. Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 2011, 51:169-187.
31. Bucci M., Papapetropoulos A., Vellecco V., Zhou Z., Pyriochou A., Roussos C., et al. Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 2010, 30(10):1998-2004.
32. Tang G., Wu L., Wang R. Interaction of hydrogen sulfide with ion channels. Clin Exp Pharmacol Physiol 2010, 37:753-763.
33. Peers C., Bauer C.C., Boyle J.P., Scragg J.L., Dallas M.L. Modulation of ion channels by hydrogen sulfide. Antioxid Redox Signal 2012, 17:95-105.
34. Tang G., Wu L., Liang W., Wang R. Direct stimulation of KATP channels by exogenous and endogenous hydrogen sulphide in vascular smooth muscle cells. Mol Pharmacol 2005, 68:1757-1764.
35. Tian X.Y., Wong W.T., Sayed N., Luo J., Tsang S.Y., Bian Z.X., et al. NaHS relaxes rat cerebral artery in vitro via inhibition of l-type voltage-sensitive Ca2+ channel. Pharmacol Res 2012, 65:239-246.
36. + channels contributes to NaHS-induced membrane hyperpolarization and relaxation in the rat coronary artery. Vascul Pharmacol 2010, 53:94-98.